A curated list of resources, papers, software, and tools at the intersection of quantum computing, quantum-inspired methods, and drug discovery.
Please read the contribution guidelines before contributing.
- Review Papers & Perspectives
- Quantum Chemistry & Molecular Simulation
- Molecular Docking & Virtual Screening
- Protein Folding
- Peptide & Antibody Design
- RNA & Genomics
- Quantum Machine Learning for Drug Discovery
- Drug Combination & Optimization
- Datasets & Benchmarks
- Software & Tools
- Learning Resources
- Quantum Hardware Platforms
- Biochemical Quantum Hardware
- Companies & Startups
- Industry Partnerships & Consortia
- Contributing
- License
Comprehensive reviews and strategic perspectives on quantum computing applications in drug discovery.
- Quantum computing for drug discovery - Early perspective on quantum computing opportunities in pharma. (IEEE, 2018)
- Quantum chemistry in the age of quantum computing - Comprehensive review of quantum algorithms for chemistry. (Chemical Reviews, 2019)
- The prospects of quantum computing in computational molecular biology - Foundational review of quantum computing prospects in molecular biology. (WIREs Comput. Mol. Sci., 2020)
- Quantum Computing for Molecular Biology - Road map from ETH Zurich's Quantum for Life Center covering biochemical simulations, structure prediction, and data-driven approaches. (ChemBioChem, 2023)
- A Perspective on Protein Structure Prediction Using Quantum Computers - IBM Quantum perspective on selecting protein structure problems amenable to quantum advantage, with proof-of-concept on Zika Virus NS3 Helicase. (J. Chem. Theory Comput., 2024)
- Quantum biological convergence: quantum computing accelerates KRAS inhibitor design - Commentary on the KRAS breakthrough highlighting QCBMs for navigating chemical space. (Signal Transduction and Targeted Therapy, 2025)
- Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries - Review of QNNs on gate-based quantum computers for property prediction and molecular generation. (Chemical Reviews, 2025)
- Quantum Computing in Drug Discovery: Techniques, Challenges, and Emerging Opportunities - Overview of quantum techniques, current challenges, and emerging opportunities in pharmaceutical applications. (Current Drug Discovery Technologies, 2025)
- Quantum intelligence in drug discovery: Advancing insights with quantum machine learning - Review of QML applications including property prediction, docking simulations, and de novo design. (Drug Discovery Today, 2025)
- Prioritizing quantum computing use cases in the drug discovery and development pipeline - Industry perspective on prioritizing QC applications across the drug development pipeline. (Drug Discovery Today, 2025)
- Quantum-machine-assisted drug discovery - Review examining quantum approaches for molecular simulation, drug-target interaction prediction, and clinical trial optimization. (npj Drug Discovery, 2026)
- BCG Survey - 8 of top 10 biopharma companies piloting quantum projects. (BCG, 2023)
- McKinsey: The quantum revolution in pharma - Strategic overview of quantum opportunities in life sciences. (McKinsey, 2025)
Quantum approaches for accurate molecular energy calculations, excited-state simulation, and hybrid workflows.
- High-Quality Protein Force Fields with Noisy Quantum Processors - Resource estimates and workflow for improving biomolecular force fields via quantum chemistry. (arXiv, 2019)
- Quantum chemical simulations of excited states - Methods for computing excited electronic states relevant to photopharmacology. (arXiv, 2021)
- Reliably assessing the electronic structure of cytochrome P450 on today's classical computers and tomorrow's quantum computers - Boehringer Ingelheim, Google, and QSimulate CYP450 benchmark introducing BLISS+THC for quantum resource reduction. (npj Quantum Information, 2022)
- Drug design on quantum computers - Comprehensive study on quantum methods for drug-relevant molecular simulations. (Nature Physics, 2024)
- Shortcut to chemically accurate quantum computing via density-based basis-set correction - Qubit Pharmaceuticals and Sorbonne University method reducing qubit requirements for molecular simulation. (Nature Communications, 2024)
- Faster Quantum Chemistry Simulations on a Quantum Computer with Improved Tensor Factorization and Active Volume Compilation - PsiQuantum and Boehringer Ingelheim report 234x speedup for CYP450 and 278x for FeMoco using Active Volume compilation. (PRX Quantum, 2025)
- Challenges and Advances in the Simulation of Targeted Covalent Inhibitors Using Quantum Computing - Review of QM/MM scoring functions, warhead reactivity, and quantum computing opportunities for covalent drugs. (J. Phys. Chem. Lett., 2025)
- Solvent configuration prediction using quantum computing - PASQAL collaboration on protein hydration analysis using neutral-atom quantum computers. (Phys. Rev. Research, 2024)
- A hybrid quantum computing pipeline for real world drug discovery - Practical hybrid quantum-classical pipeline for prodrug activation and covalent bond simulations. (Scientific Reports, 2024)
- Approximate quantum circuit compilation for proton-transfer kinetics on quantum processors - Algorithmiq, AstraZeneca, and Hartree Centre achieve 54% reduction in noisy operations using hardware-adapted fermion-to-qubit mappings. (Phys. Chem. Chem. Phys., 2026)
Quantum and quantum-inspired approaches for ligand docking, pose prediction, and large-scale screening.
- Molecular docking with Gaussian Boson Sampling - Xanadu/ProteinQure collaboration showing photonic quantum devices can predict docking configurations via maximum weighted clique reductions. (Science Advances, 2020)
- Molecular Docking Using Quantum Mechanical-Based Methods - Review of QM-based docking for improved accuracy. (Methods Mol. Biol., 2020)
- Multibody molecular docking on a quantum annealer - Multibody docking formulation mapped to quantum annealing for biomolecular interaction problems. (arXiv, 2022)
- Molecular docking via quantum approximate optimization algorithm - Pharmacophore-based approach using labeled distance graphs. (arXiv, 2024)
- Quantum molecular docking with quantum-inspired algorithm - QA-inspired binary encodings and hopscotch simulated bifurcation for rugged docking energy landscapes; compared against AutoDock Vina and DiffDock. (arXiv, 2024; JCTC 2024: 10.1021/acs.jctc.4c00141)
- Quantum-Inspired Machine Learning for Molecular Docking - Quantum-inspired optimization combined with diffusion models for blind docking. (arXiv, 2024)
- Quantum Approximate Optimization Algorithms for Molecular Docking - Pfizer-led research mapping docking to maximum vertex weight clique, solved with QAOA and DC-QAOA. (arXiv, 2025)
- Quantum algorithm for protein-ligand docking sites identification - Grover-based algorithm for binding site identification, validated on IBM quantum hardware. (J. Comput. Aided Mol. Des., 2025)
- Molecular unfolding formulation with enhanced quantum annealing - D-Wave implementation for molecular unfolding in geometric docking, showing 42.5% mean speedup over classical GeoDock. (arXiv, 2024)
- Quantum Algorithm for Structure-Based Virtual Drug Screening Using Classical Force Fields - Uses qubits to evaluate many ligand configurations in superposition while computing binding energies from classical force-field terms. (arXiv, 2025)
Quantum algorithms and comparative studies for protein and peptide folding.
- A quantum alternating operator ansatz with hard and soft constraints for lattice protein folding - QAOA-style approach splitting optimization into hard and soft constraints. (arXiv, 2018)
- Coarse-grained lattice protein folding on a quantum annealer - Improved Ising-type encodings on D-Wave with record lattice folding of Chignolin and Trp-Cage. (arXiv, 2018)
- Resource-efficient quantum algorithm for protein folding - Introduced CVaR-VQE for tetrahedral-lattice protein folding. (npj Quantum Information, 2021)
- Quantum walks for protein and peptide folding - Quantum-walk-based structure prediction in 3D. (PLOS Comput. Biol., 2021)
- Quantum synergy in peptide folding: CVaR-VQE vs molecular dynamics - Comparative study of 50 peptides showing CVaR-VQE outperforming MD for global optimization. (Int. J. Biol. Macromol., 2024)
- A comparative insight into peptide folding with quantum CVaR-VQE algorithm - Benchmarks CVaR-VQE against MD and Hidden Markov Models. (Quantum Inf. Process., 2024)
- QuPepFold: A Python package for hybrid quantum-classical protein folding simulations - Modular package targeting intrinsically disordered regions on Qiskit Aer, Amazon Braket, and IonQ Aria-1. (PLOS ONE, 2025)
- Capturing Protein Free Energy Landscape using Efficient Quantum Encoding - FCC lattice encoding with Miyazawa-Jernigan potential, validated on IBM 133-qubit hardware. (arXiv, 2025)
- Quantum-Enabled Protein Folding of Disordered Regions in Ubiquitin C - Error-mitigated VQE for Ubiquitin C terminal region folding. (IEEE, 2025)
Quantum methods specifically targeting biologics discovery.
- Quantum computing for protein design - Approaches for computational protein and peptide engineering.
- Quantum algorithms for antimicrobial peptides - Includes membrane environmental effects without additional qubits.
- De Novo Design of Protein-Binding Peptides by Quantum Computing - Multiscale framework combining D-Wave quantum annealer with classical atomistic docking for peptide design. (J. Chem. Theory Comput., 2025)
Quantum computing applications for RNA structure prediction and genomic analysis.
- Predicting RNA secondary structure using quantum computing - RNA folding formulated as combinatorial optimization on quantum hardware. (bioRxiv, 2021)
- Quantum computing applications in genomics - Survey of quantum approaches for genomic data analysis. (Applied Sciences, 2021)
Applications of QML to molecule generation, molecular property prediction, and drug-target modeling.
- Quantum Generative Models for Small Molecule Drug Discovery - Qubit-efficient hybrid quantum GAN generator for learning molecular distributions; includes code. (arXiv, 2021)
- Quantum computing for near-term applications in generative chemistry and drug discovery - Review of NISQ-era quantum applications for de novo molecular generation. (Drug Discovery Today, 2023)
- Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry - Insilico/Zapata/U of T hybrid MolGAN-CQ with quantum discriminator outperforming classical GANs on drug-likeness metrics. (J. Chem. Inf. Model., 2023)
- Hybrid quantum-classical machine learning for generative chemistry and drug design - Hybrid architectures combining quantum circuits with classical networks for molecule generation and property optimization. (Scientific Reports, 2023)
- Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors - First experimentally validated quantum drug discovery study; hybrid QCBM-LSTM screened 1M+ molecules and identified active KRAS binders. (Nature Biotechnology, 2025)
- Bridging Quantum and Classical Computing in Drug Design: Architecture Principles for Improved Molecule Generation - Empirical architecture guidelines for hybrid quantum-classical molecular GANs via Bayesian optimization. (arXiv, 2025)
- QCA-MolGAN: Quantum Circuit Associative Molecular GAN with Multi-Agent Reinforcement Learning - QCBM-enabled GAN with multi-agent RL to steer QED/LogP/SA objectives for drug-like molecules. (arXiv, 2025)
- Quantum machine learning algorithms for drug discovery applications - Benchmark study using SVM and data reuploading classifier on SARS-CoV-2 and TB datasets. (J. Chem. Inf. Model., 2021)
- Hybrid Quantum Neural Network for Drug Response Prediction - Hybrid QNN for predicting drug response from cell line and chemical inputs. (Cancers, 2023)
- Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery - QML models for ADMET property prediction, a key drug discovery bottleneck. (J. Chem. Inf. Model., 2023)
- Robust quantum reservoir computing for molecular property prediction - Quantum reservoir computing for predicting biological activity from molecular descriptors. (arXiv, 2024)
- QKDTI: A quantum kernel based machine learning model for drug target interaction prediction - Quantum-kernel SVR approach evaluated on DAVIS and KIBA, validated on BindingDB. (Scientific Reports, 2025)
- Q2SAR: A Quantum Multiple Kernel Learning Approach for Drug Discovery - Quantum multiple-kernel learning for QSAR classification (DYRK1A inhibitors). (arXiv, 2025)
Quantum methods focused on combinatorial treatment strategies and constrained molecular optimization.
- Q-Drug: A Framework to bring Drug Design into Quantum Space - Deep learning combined with quantum annealing for molecular optimization. (arXiv, 2023)
- Towards quantum computing for clinical trial design and optimization - IBM and Cleveland Clinic perspective on quantum optimization for trial site selection and cohort identification. (Trends in Pharmacological Sciences, 2024)
- Network-based prediction of drug combinations with quantum annealing - QUBO formulation using network medicine's complementary exposure principle for combination therapy discovery. (arXiv, 2025)
- Quantum-Aided Drug Design (QuADD) - PolarisQB's D-Wave-based platform for constrained molecular optimization.
- BindingDB - Measured binding affinities for protein-ligand interactions; widely used for DTI benchmarks.
- ChEMBL - Open bioactivity database for drug-like molecules and targets.
- MoleculeNet - Benchmark suite of molecular ML datasets commonly used for property prediction. (J. Chem. Inf. Model., 2018)
- Polaris - Registry of benchmark datasets for AI models in drug discovery.
- RCSB Protein Data Bank (PDB) - Structural biology database for protein targets and complexes.
- Therapeutics Data Commons (TDC) - ML-ready datasets and benchmarks spanning targets, molecules, and clinical outcomes. (NeurIPS, 2021)
- ZINC - Database of commercially available compounds for virtual screening.
- QMugs: Quantum Mechanical Properties of Drug-like Molecules - Large-scale dataset with DFT-calculated properties for drug-like molecules and molecular conformers. (Scientific Data, 2022)
- A performance characterization of quantum generative models - Benchmarking QCBM/QGAN variants useful for selecting architectures in molecular generation pipelines. (arXiv, 2023)
- QDockBank: A Dataset for Ligand Docking on Protein Fragments Predicted on Utility-Level Quantum Computers - Protein-fragment structures for docking benchmarks generated via superconducting quantum processors. (arXiv, 2025)
Frameworks, SDKs, and practical repositories for quantum drug discovery workflows.
- InQuanto - Quantinuum's quantum computational chemistry platform for molecular simulation workflows.
- OpenFermion - Google's library for compiling and analyzing quantum algorithms for chemistry.
- PennyLane - Xanadu's cross-platform library for differentiable quantum chemistry.
- Qiskit Nature - IBM's quantum chemistry module including ground-state, excited-state, and dipole calculations.
- QURI SDK - QunaSys toolkit for gate-based quantum workflows with chemistry and algorithm modules.
- Tangelo - Quantum chemistry simulation toolkit originally created by Good Chemistry Company, now maintained by SandboxAQ.
- TenCirChem - Tencent's efficient quantum chemistry simulation package built on TensorCircuit.
- TEQUILA - Open-source framework for rapid development of variational quantum algorithms with chemistry applications (Aspuru-Guzik group).
- Amazon Braket SDK - AWS SDK for quantum computing across multiple hardware backends.
- Cirq - Google's framework for NISQ circuits.
- CUDA-Q - NVIDIA's open-source platform for hybrid quantum-classical application development.
- D-Wave Ocean SDK - Tools for quantum annealing optimization problems.
- dimod - Shared API for Ising and QUBO models.
- Qiskit - IBM's comprehensive quantum computing SDK.
- Qiskit Machine Learning - Qiskit add-on for quantum kernels, QNNs, and hybrid ML workflows.
- AWS Quantum Computing Exploration for Drug Discovery - Notebooks for molecular unfolding (QUBO), RNA folding, protein folding (VQE, Grover), and retrosynthetic planning.
- Quantum-ML-Drug-discovery - Tutorial repository demonstrating QML approaches for drug discovery.
- QuPepFold - Python package for CVaR-VQE peptide folding simulations with hardware-agnostic design.
Educational materials and hands-on tutorials for getting started quickly.
- Qiskit Textbook - Quantum Chemistry - VQE for molecular ground states.
- PennyLane Quantum Chemistry Demos - Interactive tutorials on quantum chemistry algorithms.
- AWS Quantum Drug Discovery Workshop - Hands-on notebooks covering molecular unfolding, protein folding, and retrosynthetic planning.
- NVIDIA CUDA-Q: Molecular docking via DC-QAOA - Tutorial implementing DC-QAOA docking (based on arXiv:2308.04098).
- MATLAB Protein Folding VQE Example - Step-by-step VQE implementation for neuropeptide folding.
Hardware providers with relevance to molecular simulation and drug discovery workflows.
- Google Quantum AI - Superconducting processors; partner collaborations include Boehringer Ingelheim.
- IBM Quantum - Superconducting quantum processors; pharma collaborations include Cleveland Clinic (Discovery Accelerator) and Moderna (mRNA design).
- IonQ - Trapped-ion quantum computers available via Amazon Braket and Azure Quantum.
- Quantinuum - H-Series trapped-ion systems with high fidelity; Microsoft partnership demonstrated 12 logical qubits for chemistry (2024).
- Rigetti - Superconducting quantum processors available via Rigetti QCS and Amazon Braket.
- PsiQuantum - Photonic quantum computing; pharma collaborations include Boehringer Ingelheim (CYP450 simulation).
- Xanadu - Photonic quantum computing; creators of PennyLane and Strawberry Fields, with applications including Gaussian Boson Sampling.
- D-Wave - 5000+ qubit annealing systems used in molecular docking and constrained optimization.
- PASQAL - Neutral-atom processors; partner collaborations include Qubit Pharmaceuticals.
- QuEra Computing - Neutral-atom systems with collaborations including Merck KGaA and Amgen.
Biomolecular systems as quantum computing platforms.
- Peptides as Versatile Platforms for Quantum Computing - Lanthanide-binding peptide tags as molecular qubits demonstrating coherent oscillations via pulsed EPR. (J. Phys. Chem. Lett., 2018)
Organizations building products and services at the intersection of quantum computing and drug discovery.
- Algorithmiq (Finland) - Aurora platform with IBM partnership, quantum network medicine focus, and Cleveland Clinic cancer drug collaboration.
- Aqemia (France) - Quantum-inspired statistical mechanics for affinity prediction.
- Kuano (UK) - Quantum machine learning for molecular discovery.
- Menten AI (USA/Canada) - Quantum-enhanced peptide and protein design.
- Phasecraft (UK) - Quantum algorithms for drug discovery; Wellcome Leap Q4Bio covalent inhibitor project with University of Nottingham and QuEra.
- Polaris Quantum Biotech (PolarisQB) (USA) - QuADD platform on D-Wave for lead identification and constrained molecular optimization.
- ProteinQure (Canada) - Peptide drug discovery with long-term quantum R&D focus.
- QC Ware (USA) - Promethium quantum chemistry SaaS platform; partnerships include Merck KGaA and NVIDIA Quantum Cloud integration.
- QSimulate (USA) - Ab initio quantum simulation for drug discovery.
- Qubit Pharmaceuticals (France/USA) - Atlas platform combining HPC simulation with quantum algorithms; WEF Technology Pioneer 2024.
- SandboxAQ (USA) - Developer of Tangelo and AQChemSim (formerly QEMIST Cloud); collaborations include AstraZeneca and Sanofi.
- XtalPi (China/USA) - ID4 platform combining quantum mechanics and AI; partnerships include Pfizer.
- 1QBit (Canada) - Quantum software provider; pharma partnership history includes Biogen (via Accenture).
- HQS Quantum Simulations (Germany) - Quantum chemistry software; three-year partnership with Merck KGaA for drug screening and molecular property prediction.
- QunaSys (Japan) - Quantum chemistry software company and lead coordinator of the QuEnAIS quantum-AI drug discovery consortium.
Collaborative initiatives advancing quantum drug discovery.
- IBM Quantum Network - Includes Cleveland Clinic (Discovery Accelerator), Moderna, and multiple pharma partners.
- QIDO - Quantum-Integrated Discovery Orchestrator platform by Mitsui, QSimulate, and Quantinuum for drug and materials discovery; beta tested by Chugai Pharmaceutical (2025).
- QuEnAIS - Quantum-AI drug discovery consortium led by QunaSys.
- QuPharm - Alliance of pharmaceutical companies developing quantum computing solutions for drug discovery.
- SEEQC Consortium - UK-led project with Oxford University and Merck KGaA to build full-stack quantum systems for pharma applications.
- Wellcome Leap Q4Bio - Program supporting quantum-enabled biological and pharmaceutical research; Phase 3 projects (2025) include Phasecraft/QuEra covalent inhibitor work.
- Novo Holdings - DKK 1.4 billion (~€188M) commitment to quantum computing in life sciences, with portfolio including Phasecraft and Sparrow Quantum (2024).
- Amgen - QuEra collaboration for molecular property prediction.
- AstraZeneca - SandboxAQ and Riverlane partnerships.
- Biogen - 1QBit/Accenture quantum molecular comparison validation.
- Boehringer Ingelheim - Collaborations with Google Quantum AI and PsiQuantum (CYP450 simulation); studies including quantum chemistry for metalloenzymes.
- Johnson & Johnson - Patent filings and quantum research programs.
- Merck KGaA - Multiple initiatives including SEEQC consortium, QC Ware partnership, and QuEra collaboration.
- Moderna - IBM collaboration for mRNA medicine design.
- Pfizer - Quantum algorithm development for molecular docking and simulation.
- Roche - Internal quantum research programs and startup collaborations.
- Sanofi - SandboxAQ partnership for molecular simulation and AI-driven biomarker identification in clinical development (2024).
Contributions welcome! Please read our contribution guidelines first.
When adding new resources:
- Include publication year and source
- Provide brief description of the quantum method used
- Link to papers, code repositories, or official documentation
- Verify links are accessible
To the extent possible under law, the contributors have waived all copyright and related or neighboring rights to this work.
Curated by Mark Fingerhuth, passionate about the intersection of quantum computing and drug discovery. For the latest in open-source quantum software more broadly, see Awesome Quantum Software.